	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	5.30	3.87	0.58	37.0%	813.8%
Operating Profit Qtr	0.13	0.22	-0.07	-40.9%	285.7%
Net Profit Qtr	0.15	0.13	-0.03	15.4%	600.0%
Earning Per Share Adjusted latest Qtr	0.15	0.13	-0.03	15.4%	600.0%

* Standalone data

Detailed Results

Novelix Pharmaceuticals Ltd.

13 Feb 2025

Company Update

Trimurthi Ltd - 536565 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Quarterly result for financial year ended on 31st December 2024.

pdf

Novelix Pharmaceuticals Ltd.

12 Feb 2025

Board Meeting

Trimurthi Ltd - 536565 - Board Meeting Outcome for Approval Of Quarterly Financial Statements

BSE India

Considered, reviewed and approved the Unaudited Financial Statements for the Quarter Ended 31st December 2024

pdf

Novelix Pharmaceuticals Ltd.

12 Feb 2025

Company Update

Trimurthi Ltd - 536565 - Announcement under Regulation 30 (LODR)-Change in Management Control

BSE India

Appointment of Mr. Lakshman Samala as Independent Director and Ms. Bhoomika Choudhary Chief Financial officer.

pdf

Novelix Pharmaceuticals Ltd.

06 Feb 2025

Board Meeting

Trimurthi Ltd - 536565 - Board Meeting Intimation for Prior Intimation Of The Board Meeting To …

BSE India

Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th February 2025 at 05:00 P.M. at the Registered office of the Company, inter-alia to discuss the following: 1. To consider, approve and take on record the unaudited Financial Results of the company for the quarter ended 31st December 2024. 2. To consider and take note of Limited Review Report for the quarter ended 31st December 2024. 3. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter ended 31st December 2024. 4. Any other item with the approval of the chairman.

pdf

Novelix Pharmaceuticals Ltd.

15 Jan 2025

Company Update

Trimurthi Ltd - 536565 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74(5) for December 2024

pdf

Novelix Pharmaceuticals Ltd.

10 Jan 2025

Company Update

Trimurthi Ltd - 536565 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Allotment of 1,50,00,000 Warrants and the company has received 25% of the issue price.

pdf

Novelix Pharmaceuticals Ltd.

26 Dec 2024

SAST

Trimurthi Ltd - 536565 - Closure of Trading Window

BSE India

Closure of Trading Window of the Company from 1st Jan 25 till 48 hours from the conclusion of Board Meeting in which the Financials results for the quarter ended 31st Dec 24 will be approved.

pdf

Novelix Pharmaceuticals Ltd.

19 Nov 2024

AGM

Trimurthi Ltd - 536565 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Scrutinizer Report of the EGM

pdf

No results found

Is Trimurthi Ltd. worth buying?

7 Votes:

Buy 85.71%

Sell 14.29%